Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Interest Expenses (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Interest Expenses for 15 consecutive years, with $1.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Interest Expenses rose 96.01% year-over-year to $1.8 million, compared with a TTM value of $6.2 million through Sep 2025, up 192.27%, and an annual FY2024 reading of $3.1 million, up 557.53% over the prior year.
  • Interest Expenses was $1.8 million for Q3 2025 at Sanara MedTech, up from $1.8 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $1.8 million in Q3 2025 and bottomed at $6.0 in Q1 2023.
  • Average Interest Expenses over 5 years is $669597.7, with a median of $287483.0 recorded in 2023.
  • The sharpest move saw Interest Expenses plummeted 91.49% in 2021, then skyrocketed 4455500.0% in 2024.
  • Year by year, Interest Expenses stood at $711.0 in 2021, then surged by 15327.43% to $109689.0 in 2022, then surged by 162.09% to $287483.0 in 2023, then soared by 348.42% to $1.3 million in 2024, then skyrocketed by 41.03% to $1.8 million in 2025.
  • Business Quant data shows Interest Expenses for SMTI at $1.8 million in Q3 2025, $1.8 million in Q2 2025, and $1.3 million in Q1 2025.